Zeta Global $ZETA Earnings Report Poses 20% Swing Risk: $12.60...
Key Takeaways Zeta Global’s stock is at a technical crossroads ahead of its Q2 earnings, with analysis pointing to a potential 20% upside to $19 or a corresponding downside risk...
Key Takeaways Zeta Global’s stock is at a technical crossroads ahead of its Q2 earnings, with analysis pointing to a potential 20% upside to $19 or a corresponding downside risk...
Key Takeaways Snap Inc.’s upcoming earnings report is widely viewed as a potential trigger for a sharp share price decline, with investors monitoring for any signs of operational weakness. Analysis...
Key Takeaways MercadoLibre’s recent earnings per share (EPS) miss was not a result of operational failure, but a consequence of deliberate investments designed to secure long-term market dominance. Strategic margin...
Key Takeaways MercadoLibre’s recent earnings per share (EPS) miss is not a sign of weakness but a deliberate consequence of aggressive, front-loaded investments in high-growth areas like logistics and marketing....
Key Takeaways Redwire Corporation is strategically pivoting to integrate its space technology expertise with defence systems, particularly in the uncrewed aerial systems (UAS) sector, mirroring the disruptive approach of firms...
Key Takeaways Quantum BioPharma has announced positive Phase 1 trial results for its multiple sclerosis drug, Lucid-21-302, which targets myelin repair without immune system suppression. The study demonstrated a strong...
Key Takeaways Global Partners LP has reaffirmed its full-year 2025 guidance, projecting revenue of $2.3 billion to $2.4 billion and adjusted EBITDA of $295 million to $335 million, despite acknowledged...
Key Takeaways Goldman Sachs forecasts three successive quarter-point Fed rate cuts for September, October, and December 2025, signalling a steady easing cycle. The projection is predicated on softening economic indicators,...
Key Takeaways DLocal has introduced SmartPix, the first Pix-on-file system in Brazil, designed to facilitate seamless recurring payments by tokenizing customer credentials. The system aims to address a critical gap...
Key Takeaways The FDA’s exclusive authorisation of a specialised cannula for delivering the KEBILIDI gene therapy establishes a significant commercial moat, making the device indispensable for clinical application. This regulatory...
CTA Content